Federal: Other MH Policy

Project ALIGN represents an early-stage but potentially significant shift in how autism therapy documentation and progress measurement will be standardized across the industry. If the coalition succeeds in establishing consensus around the EarliPoint eye-tracking tool for longitudinal measurement, your practice's documentation burden could decrease substantially—particularly the time your master's-level clinicians currently spend on manual data collection and progress tracking. This matters financially because clinician time currently devoted to assessment paperwork is not billable in most reimbursement models; automating this through objective, standardized measurement could free 5-10 hours per week per clinician for direct patient care or higher-billable activities. However, adoption of EarliPoint's FDA-cleared tool requires capital investment (device purchase, staff training, software integration), and small solo practices or under-resourced agencies may face barriers to participation. The real leverage comes if payers begin requiring or incentivizing these standardized metrics for reimbursement decisions—a scenario that could emerge within 18-36 months as the coalition demonstrates data reliability. Currently, each payer-provider relationship operates independently on outcome measurement, meaning you likely submit different progress formats to different insurers; standardization could streamline prior authorization narratives and reduce denials related to 'insufficient clinical justification.' That said, participation is voluntary and industry-led rather than mandated, so there is no compliance deadline. Your practice should monitor whether your primary payers (Medicaid managed care organizations, commercial plans covering autism services in your state) begin requesting EarliPoint-compatible data or outcomes metrics.